International Biotechnology Trust’s Array Biopharma Inc ARRY Stock Holding History

International Biotechnology Trust’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-72,500	Closed	-$1.77M	–	70
2019 Q1	$1.77M	Hold	72,500	–	–	0.65%	40
2018 Q4	$811K	Sell	72,500 -772,000	-91%	-$11.7M	0.5%	36
2018 Q3	$9.84M	Buy	844,500 +150,000	+22%	+$2.3M	4.68%	5
2018 Q2	$11.6M	Sell	694,500 -157,000	-18%	-$2.5M	4.47%	5
2018 Q1	$13.9M	Buy	851,500 +374,000	+78%	+$5.99M	5.42%	3
2017 Q4	$6.11M	Buy	477,500 +230,000	+93%	+$2.62M	2.15%	17
2017 Q3	$3.04M	Sell	247,500 -73,244	-23%	-$680K	1.18%	26
2017 Q2	$2.68M	Buy	320,744 +243,244	+314%	+$1.99M	1.02%	31
2017 Q1	$693K	Buy	77,500 +12,500	+19%	+$133K	0.27%	57
2016 Q4	$571K	Buy	+65,000	New	+$478K	0.26%	45

Other funds holding ARRY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

International Biotechnology Trust's ARRY Position: Q2 2019 in Review

International Biotechnology Trust sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 72,500 shares — an estimated $1.77M sold.

International Biotechnology Trust first reported a position in ARRY in Q4 2016 and held it in 10 quarters. The position peaked at $13.9M in Q1 2018. 318 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

International Biotechnology Trust reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
International Biotechnology Trust sold 72,500 Array Biopharma Inc shares in Q2 2019, an estimated $1.77M.
International Biotechnology Trust first reported a position in Array Biopharma Inc in Q4 2016 and held it in 10 quarters.
International Biotechnology Trust's Array Biopharma Inc position peaked at $13.9M in Q1 2018.
318 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on International Biotechnology Trust's 13F filing for Q2 2019, filed 14 Aug 2019.